Polycystic ovary syndrome: implications of corticotropin in the regulation of blood pressure, aldosterone, and androgen secretion.
Armanini
Decio
D
Pellati
Donatella
D
Fiore
Cristina
C
D000324:Adrenocorticotropic Hormone / Q000096:biosynthesis / Q000097:blood* / Q000187:drug effects; D000450:Aldosterone / Q000096:biosynthesis / Q000097:blood*; D015415:Biomarkers; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000378:metabolism / Q000503:physiopathology*; D012307:Risk Factors; D013148:Spironolactone / Q000627:therapeutic use
D015415:Biomarkers; D013148:Spironolactone; D000450:Aldosterone; D000324:Adrenocorticotropic Hormone